Dokter Pengangkatan sebagian tumor dan saraf mata terbaik di dunia — TOP 24

Kepala dokter dan profesor. Pakar Tingkat 1 di Pusat Kanker, West China Hospital, Universitas Sichuan (peringkat ke-2 di Tiongkok). Menyelesaikan fellowship pascadoktoral dalam radiologi intervensi di Rumah Sakit Umum PLA Tiongkok. Memimpin perawatan tim multidisiplin (MDT) untuk tumor kompleks. Pakar dalam onkologi intervensi minimal invasif untuk kanker hati, paru-paru, dan pankreas.

Akreditasi: Anggota Dewan WATA. Anggota komite CACA dan CMDA tentang intervensi, ablasi, biji radioaktif, dan nyeri. Pada tahun 2023, anggota direktur perdana Komite Perawatan Paliatif, Asosiasi Medis Sichuan. Anggota dewan redaksi Chinese Journal of Interventional Imaging and Therapy. Anggota dewan redaksi Chinese Journal of Pain Medicine.

Memimpin 2 proyek sains & teknologi provinsi dan 2 proyek NSFC. Memiliki 40+ makalah, dengan 30+ sebagai penulis pertama atau koresponden. Faktor dampak tertinggi: 10,73. Kohort karsinoma hepatoseluler (HCC): TACE + lenvatinib vs TACE + sorafenib. OS 18,97 vs 10,77 bulan. PFS 10,6 vs 5,4 bulan. ORR 66,8% vs 33,3%.

Profesor Xiao Yueyong adalah Kepala Dokter di Departemen Diagnostik Radiologi di Rumah Sakit Umum Tentara Pembebasan Rakyat Tiongkok. Beliau adalah pakar terkemuka dalam onkologi intervensi minimal invasif. Beliau menjabat sebagai presiden perdana WATA (2025–). Beliau adalah presiden Masyarakat Internasional (2020–) dan Asia (2012–) untuk Krioterapi. Beliau juga merupakan Wakil Kepala Kelompok Pakar NHC tentang peraturan ablasi tumor (2009–).

Beliau telah melakukan lebih dari 100.000 prosedur minimal invasif yang dipandu CT/MRI. Pekerjaannya mencakup ablasi kimia, RFA, MWA, krioablasi, dan NanoKnife (IRE). Beliau memperkenalkan dan memajukan ablasi NanoKnife di Tiongkok. Beliau memimpin standar nasional pertama untuk krioablasi tumor dan NanoKnife.

Penghargaan termasuk Penghargaan Kontribusi Khusus Nasional (Kehormatan seumur hidup). Beliau menerima Hadiah Pertama dari Asosiasi Pendidikan Kedokteran Tiongkok (2021). Beliau menerima dua Hadiah Kedua untuk Prestasi Medis Militer (2016, 2018) dan dua Hadiah Kedua dari Asosiasi Anti-Kanker Tiongkok (2019, 2022). Beliau dinobatkan sebagai Master Ablasi Asia. Catatan penelitiannya mencakup 13 paten Tiongkok. Beliau adalah peneliti utama untuk empat proyek NSFC dan satu subjek MOST. Beliau telah menerbitkan lebih dari 200 makalah, dengan lebih dari 110 sebagai penulis pertama atau koresponden dan lebih dari 40 di jurnal SCI. Beliau telah memimpin lebih dari 10 pedoman atau pernyataan konsensus ablasi.

Dr. Solak berspesialisasi dalam kanker kepala dan leher, dengan pelatihan fellowship di Institut Kanker Universitas Hacettepe.

• Terlatih di MD Anderson Cancer Center, University of Texas
• Berpengalaman dalam prosedur pengangkatan tumor yang kompleks
• Bekerja di Hisar Hospital Intercontinental

Dr. Xavier Centeno Fornies berlatih di Mayo Clinic dan memimpin departemen bedah di Centro Médico Teknon.

• Spesialis bedah kolorektal dengan pelatihan tambahan di Mayo Clinic
• Anggota American Society of Colon and Rectal Surgeons
• Terakreditasi oleh ERAS-Society untuk protokol pemulihan yang ditingkatkan

Direktur Layanan Neuro-onkologi di Sourasky Medical Center – Dr. Blumental berspesialisasi dalam kasus tumor kompleks yang melibatkan mata dan saraf.

• Terlatih di Memorial Sloan-Kettering Cancer Center
• Neuro-onkolog senior dengan pengalaman lebih dari _doctor_769_ tahun
• Sebelumnya memimpin Layanan Neuro-onkologi di Huntsman Cancer Institute
• Berfokus pada teknik pengangkatan tumor presisi

Dr. Alemdar berspesialisasi dalam onkologi medis dengan pelatihan ekstensif di Rumah Sakit Universitas Akdeniz.

• Bersertifikat dewan dalam onkologi medis sejak 2018
• Lebih dari _doctor_9570_ tahun pengalaman dalam penyakit dalam dan onkologi
• Pernah bekerja di beberapa rumah sakit bergengsi termasuk Rumah Sakit Universitas Akdeniz

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Prof. Dr. Gül Alço adalah ahli onkologi radiasi dengan pengalaman sekitar 27 tahun. Beliau menangani kanker payudara, paru-paru, prostat, saluran pencernaan, ginekologi, sistem saraf pusat, kepala dan leher, jaringan lunak, serta tulang dengan radioterapi.

Keahliannya meliputi radioterapi adaptif dan bedah radiasi (radiosurgery). Beliau menggunakan teknik radiasi canggih untuk memberikan perawatan yang dipersonalisasi dan berbasis bukti dalam lingkungan multidisiplin yang berpusat pada pasien.

Prof. Dr. Abdullah Sakin adalah profesor onkologi medis. Beliau menangani tumor padat, termasuk kanker paru-paru, payudara, gastrointestinal, genitourinari, ginekologi, kanker kepala dan leher, serta melanoma.

Beliau memberikan perawatan yang dipersonalisasi dan berbasis bukti. Perawatannya meliputi kemoterapi, terapi target, imunoterapi, terapi hormon, dan onkologi presisi. Beliau telah menulis lebih dari 200 publikasi ilmiah dan berpartisipasi dalam penelitian klinis internasional. Pekerjaan ini memajukan perawatan kanker yang berpusat pada pasien.

Dr. Paweł Grochowicz, MD, PhD, adalah seorang proktologis dengan pengalaman hampir 40 tahun. Beliau bekerja di Pusat Proktologi Warsawa di Rumah Sakit St. Elizabeth. Beliau menangani wasir, fistula dan abses anus, fisura anus, inkontinensia tinja, dan kista pilonidal. Beliau juga melakukan kolonoskopi dan polipektomi kolorektal.

Dari tahun 1979 hingga 2016, beliau bekerja di Unit Proktologi, Rumah Sakit Solec, sebuah pusat rujukan dan satu-satunya di Polandia. Sejak 2016, beliau bekerja di Pusat Proktologi Warsawa di Rumah Sakit St. Elizabeth. Di sana, beliau mengembangkan dan menerapkan metode baru serta menjalankan pekerjaan diagnostik, rehabilitasi, penelitian, dan pengajaran. Pusat ini merupakan kantor pusat Klub Koloproktologi Polandia.

Peran akademik dan penelitian: Institut Kedokteran Eksperimental dan Klinis, Akademi Ilmu Pengetahuan Polandia (1979–1997). Penerima beasiswa DAAD di LMU Munich (1983–1984). Rumah Sakit John Hunter, Universitas Newcastle, Australia (1989–1996). Di sana, beliau menjabat sebagai Direktur Unit Penelitian Transplantasi dan Pejabat Ilmiah Utama (1991–1996).

Dr. Przemyslaw Ciesielski adalah seorang ahli bedah umum. Ia menyelesaikan spesialisasi pada tahun 2008. Ia lulus dari Universitas Kedokteran Warsawa pada tahun 1999. Ia meraih gelar Doktor Ilmu Kedokteran pada tahun 2010. Disertasinya mengevaluasi pemeriksaan klinis dan rektoskopi untuk mendiagnosis penyakit kolorektal pada pasien dengan peningkatan risiko kanker kolorektal.

Pelatihan proktologi dan kolorektalnya mencakup kursus formal dan fellowship. Ia menyelesaikan Kursus Proktologi di Rumah Sakit St. Rota di Vercelli pada tahun 2021 dan 2022, serta di Cologne pada tahun 2016. Ia menjalani fellowship klinis dalam Bedah Umum di Universitas Kedokteran Wina pada tahun 2014 dan di Universitas Magdeburg pada tahun 2015. Ia menjalani beberapa fellowship di Departemen Proktologi, Rumah Sakit Solec di Warsawa dari tahun 2005 hingga 2013. Ia menghadiri lokakarya bedah kolorektal tingkat lanjut di Poznan dan Lodz. Ia juga menyelesaikan kursus di Rumah Sakit St. Mark di London, termasuk "Frontiers in Colorectal Diseases" dan "Advanced Colorectal Workshop".

Spesialis bedah tumor intraokular – Dr. Schuler melakukan operasi rumit pada lensa dan retina mata di Klinik Bremen-Mitte.

• Lebih dari _doctor_1972_ tahun pengalaman dalam oftalmologi dan onkologi mata
• Penulis lebih dari 20 artikel ilmiah tentang perawatan mata
• Anggota American Academy of Ophthalmology dan German Ophthalmological Society
• Menyelesaikan pelatihan lanjutan di Free University of Berlin

Dr. Sridhar P.S. berspesialisasi dalam radioterapi dengan pengalaman lebih dari dua dekade dalam menangani tumor mata yang kompleks di HCG Manavata Cancer Centre.

• Menyelesaikan pelatihan lanjutan di bidang radioterapi di Banaras Hindu University
• Diplomat Dewan Nasional untuk radioterapi
• Anggota Society for Neuro-Oncology
• Bagian dari Bangalore Oncology Group
• Afiliasi dengan Indian Association of Hyperthermia Oncology

Telah menangani lebih dari 30.000 pemindaian PET dan 1.000 pasien kanker tiroid – Dr. Borde membawa keahlian kedokteran nuklir yang luas untuk prosedur tumor dan saraf.

• _doctor_2774_tahun_ pengalaman dalam kedokteran nuklir
• Mahir dalam terapi radioiodin dan Lu-177
• Menerbitkan makalah di berbagai jurnal medis
• Bekerja di HCG Manavata Cancer Centre

Dr. Shruti Kate berspesialisasi dalam perawatan tumor mata dan saraf, dengan memanfaatkan pelatihan onkologi ekstensifnya di Tata Memorial Hospital.

• Terlatih dalam onkologi medis di Tata Memorial Hospital
• Pakar tumor padat, termasuk kasus yang berhubungan dengan mata
• Anggota ASCO, ESMO, dan masyarakat onkologi terkemuka lainnya
• Mempresentasikan penelitian kanker paru-paru di Konferensi Dunia tentang Kanker Paru-paru